Mass metrology innovators, Metryx, Limited, today announced the receipt of a multiple system follow-on order from Taiwanese semiconductor memory manufacturer, Inotera Memories, Inc. The order is for Metryx's Mentor DF3 platform and will be used initially to monitor etch applications.
BioForce Nanosciences Holdings, Inc., a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that Kerry Frey, formerly President and Chief Operating Officer, will now be President and Chief Executive Officer. Eric Henderson, who was Chief Executive Officer, will now be Executive Vice President and Chief Science Officer, a newly created position.
mPhase/AlwaysReady, Inc., a micro and nanotechnology development company focused on advanced power and sensing solutions, today announced the completion of its 2008 strategic planning process, resulting in several new corporate developments that will accelerate the commercialization path of its revolutionary nanotechnology-based battery.
The money spent on printed and potentially printed electronics doubled in 2007, as did the number of organisations participating. There are now about 1500 organisations doing significant work, most of them being academic. In 2008, there will be much more emphasis on commercialisation and many more countries will join the fray.
Moscow State University and IBM announced details of an agreement to install a Blue Gene/P supercomputer at the Department of Computational Mathematics and Cybernetics. The new supercomputer, the first installation of the world famous Blue Gene computer in Russia, will be used for fundamental research in nanotechnology, new materials and life sciences.
pSivida Limited, a global drug delivery company, and Intrinsiq Materials Cayman Limited today announced that the assets of pSiNutria Limited, a wholly owned subsidiary of pSivida, has been sold to Intrinsiq Materials, a UK based venture capital backed company.
Written by the inventor of the Gas Dynamic Spray (GDS) technique, this first monograph on the topic brings the understanding of the GDS coating formation process to a new qualitative nanostructural level, while introducing it to industrial and technological experts so that they can develop a new generation of coatings materials.
Industrial Nanotech, Inc. announced that the Company's patented Nansulate energy saving protective coatings are now sold in 33 countries and applicants for Exclusive Distributor status are currently under review for the countries of Russia, India, Sweden, Brunei, Bulgaria, Romania, and Korea. Negotiations for placement of the Company's products in retail stores are underway in the US, New Zealand, Canada, and Europe.
Nanometrics Incorporated, a leading supplier of advanced metrology equipment to the semiconductor industry, will release its fourth quarter and fiscal year 2007 financial results after market close on February 20, 2008. A conference call to discuss the results will be held at 5 PM ET.
Yesterday, Onexim Group revealed its first project in the area of nanotechnology. It proposes to build a research and technology center in Moscow, which may cost more than USD 100 million to implement considering the required equipment, RBC Daily wrote today.
Zecotek Photonics Inc. officially announced the launch of its new computerized, high-power, high-resolution laser spectrometer. The device was specifically developed to meet a rapidly growing demand for higher precision spectrometry in nano- and bio-technological applications. Zecotek's latest offering pushes the limits of the precise spectral measurements and technological procedures required in these fields.
Abraxis BioScience, Inc., an integrated biotechnology company, today announced that the European Commission has granted marketing approval for ABRAXANE powder for suspension for infusion (an albumin-bound nanoparticle formulation of paclitaxel) for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.